EN

Effective Treatment of CIN III (Severe Cervical Dysplasia) in Israel with Preservation of Health and Fertility

 

What Is CIN III (Severe Cervical Dysplasia)

 

CIN III, or cervical intraepithelial neoplasia grade III, represents a precancerous condition of the cervical epithelium in which abnormal cells extend through the full thickness of the mucosal layer. Although not cancer at the time of diagnosis, CIN III carries a significant risk of progression to invasive carcinoma if left untreated.
At the clinic of Dr. Sergey Tunitsky, a leading gynecologic surgeon in Israel, every woman receives an individualized risk assessment and a personalized treatment plan focusing on organ-preserving techniques — an essential approach for patients planning future pregnancy.

 

Risk Factors for Developing CIN III

 

The primary cause of severe cervical dysplasia is persistent infection with high-risk human papillomavirus (HPV) types. However, HPV infection alone does not always lead to CIN III. Additional risk factors include a weakened immune system, long-term smoking, chronic sexually transmitted infections, hormonal imbalances, early onset of sexual activity, and multiple sexual partners.
In Israeli clinical practice, CIN III treatment goes beyond removing the affected tissue. Dr. Tunitsky’s approach includes identifying and addressing underlying risk factors — from immune modulation to treatment of concurrent infections — ensuring a comprehensive and sustainable recovery.

Symptoms of Severe Cervical Dysplasia

In most cases, CIN III is asymptomatic and detected incidentally during routine cervical screening such as a Pap smear or HPV test. Some women may notice nonspecific signs like postcoital spotting, intermenstrual bleeding, or abnormal vaginal discharge.
Any of these symptoms should prompt immediate evaluation by a gynecologic surgeon in Israel. Early diagnosis through proper examination is key to effective and fertility-sparing treatment.

 

Accurate Diagnosis of CIN III in Israel

 

Dr. Tunitsky’s clinic follows a multi-step diagnostic protocol designed to minimize diagnostic errors and precisely define the extent of cervical involvement:

  • Advanced colposcopy – detailed examination of the cervix under magnification to visualize abnormal epithelial areas.
  • Targeted biopsy – collection of tissue from the most suspicious zones for histopathological confirmation; this remains the gold standard in CIN III diagnosis.
  • Histological verification – performed in certified Israeli pathology laboratories, providing highly accurate results and, if needed, an independent second opinion.

This systematic approach ensures diagnostic precision and allows careful treatment planning tailored to each patient’s reproductive goals and medical condition.

 

Treatment Options for CIN III at Dr. Sergey Tunitsky’s Clinic

 

The main objective of CIN III treatment in Israel is the complete removal of abnormal tissue while preserving healthy cervical structure and fertility potential.

 

Dr. Tunitsky offers advanced, evidence-based therapeutic options:

  • Cervical conization – excision of the affected area in a cone shape. The procedure may be performed using traditional surgical, radiofrequency, or LEEP (Loop Electrosurgical Excision Procedure) techniques. The choice depends on lesion size, anatomical considerations, and the patient’s pregnancy plans.
  • Laser therapy or ablation – in select cases, laser vaporization is used to destroy abnormal epithelium without extensive resection.
  • Personalized postoperative follow-up – regular Pap and HPV testing combined with colposcopic monitoring to detect any recurrence at an early stage.

As a highly skilled gynecologic surgeon, Dr. Tunitsky applies minimally invasive, fertility-preserving methods tailored to each woman’s clinical needs.

 

Post-Treatment Follow-Up and Recurrence Prevention

 

Following surgical treatment, continued follow-up is essential. Patients undergo regular cytological and HPV tests, as well as scheduled colposcopies in accordance with Israeli clinical protocols.
Prevention of recurrence includes lifestyle modifications such as smoking cessation, management of chronic infections, and strengthening of immune response. HPV vaccination may also be discussed as part of post-treatment prevention according to international and Israeli recommendations.

 

Scheduling a Consultation with Dr. Sergey Tunitsky

 

If you have been diagnosed with CIN III or suspect cervical dysplasia, do not postpone professional evaluation. At Dr. Tunitsky’s clinic in Israel, patients receive comprehensive care — from accurate multi-level diagnostics to modern organ-preserving surgery and long-term monitoring.
To schedule a consultation, contact our medical coordinators. They speak Russian, English, and Hebrew, and will assist you with travel arrangements, visa documentation if needed, and personalized scheduling for your CIN III treatment in Israel.

Questions and answers about CIN III (severe cervical dysplasia) treatment in Israel with Dr. Sergei Tunitsky

Is CIN III cervical cancer or a precancerous condition?

CIN III (Cervical Intraepithelial Neoplasia grade 3) is not cancer but a precancerous condition in which abnormal cells affect the full thickness of the cervical epithelium without invading deeper tissues. Without treatment, the risk of progression to invasive cancer is very high according to modern Israeli protocols. At Dr. Sergey Tunitsky’s clinic, CIN III is treated using gentle organ-preserving methods that completely remove the lesion while preserving fertility.


How is CIN III diagnosed at Dr. Tunitsky’s clinic in Israel?

Diagnosis of severe cervical dysplasia in Israel follows strict international standards. First, a gynecological exam and colposcopy are performed, followed by a targeted cervical biopsy. The sample is analyzed in leading Israeli laboratories. If needed, Dr. Tunitsky arranges a second histological opinion to confirm the diagnosis. This approach minimizes errors and helps select the optimal treatment strategy.


What is the most effective treatment for CIN III in Israel?

The gold standard treatment is cervical conization. At Dr. Tunitsky’s clinic, the procedure is performed with high precision using radio wave (LEEP) or cold knife techniques. The choice depends on lesion depth and the patient’s reproductive plans. The main goal is complete removal of the lesion while preserving healthy tissue and fertility.


Can I become pregnant after CIN III treatment in Israel?

Yes, most women can successfully conceive after treatment. Dr. Tunitsky uses an organ-preserving approach, carefully planning the amount of tissue removed to maintain cervical integrity. Postoperative guidance includes recovery instructions and pregnancy planning. Most women deliver without complications.


Why choose CIN III treatment in Israel with Dr. Tunitsky?

Advantages include accurate diagnosis, personalized treatment, and advanced technology. Israel offers cutting-edge surgical and imaging methods, and Dr. Tunitsky has extensive experience in gynecological surgery. Each procedure considers anatomical and reproductive specifics to achieve full recovery and preserve quality of life.


What is a LEEP procedure and is it safe?

LEEP (Loop Electrosurgical Excision Procedure) is a modern radio wave method to remove abnormal cervical epithelium. It is outpatient, minimally invasive, with a short recovery period. At Dr. Tunitsky’s clinic, LEEP is used for CIN II–III and is highly effective and safe, preserving reproductive function.


What happens if severe cervical dysplasia is left untreated?

Untreated CIN III significantly increases the risk of cervical cancer. Unlike early dysplasia, observation without treatment is not recommended. Israeli protocols require active surgical intervention. Conization or radio wave excision completely removes abnormal cells and prevents malignant progression.


What role does HPV play in CIN III development?

CIN III is primarily caused by persistent high-risk HPV. At Dr. Tunitsky’s clinic, treatment addresses both the abnormal tissue and the underlying viral cause. Patients receive therapy to suppress viral activity and strengthen immunity, reducing recurrence risk after successful treatment.


How is recovery after conization in Israel?

Recovery after conization or LEEP takes 4–6 weeks. Patients receive detailed instructions in Russian, including activity, hygiene, and sexual contact recommendations. The process is monitored by Dr. Tunitsky with follow-up exams to ensure safe and complete healing.


How can I book CIN III treatment with Dr. Sergey Tunitsky in Israel?

Contact the clinic coordinators via website form or phone. The Russian-speaking team assists with scheduling, documentation, visa invitations, and trip organization. Patients from various countries come to Dr. Tunitsky for CIN III treatment following modern Israeli protocols with maximum care and support.